The Peptide Promise With NervGen's Mike Kelly - Listen -

The Peptide Promise With NervGen's Mike Kelly

Listen now

Description

We love to hear from our listeners. Send us a message. Mike Kelly faced a self-reckoning before he took the job as CEO at NervGen, a company developing peptide therapeutics targeted specifically at central nervous system repair. The veteran of life sciences business development knew the ropes of the biotech C-suite. He’d been a CEO twice before. He knew how to launch drugs, having seen commercial success several times before. He even knew how to sell them—he’d started his career carrying the ...

More Episodes

See all »

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

We love to hear from our listeners. Send us a message. In August of this year, the first TCR cell therapy to be approved for use in the U.S. was greenlighted by the FDA for patients with unresectable or metastatic synovial sarcoma who have previously received chemotherapy. It marked the first new...

Published 11/18/24

Business Of Biotech

Published 11/18/24

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

We love to hear from our listeners. Send us a message. On this episode of the Business of Biotech, Bill and Melinda Gates Medical Research Institute's (Gates MRI) Dr. Claire Wagner joins us to share insights into her work as head of Corporate Strategy and Market Access there. She shares the...

Published 11/11/24